Cidara Therapeutics, Inc. (CDTX) has a market capitalization of $5.61B and trades at $221.38. The 52-week range is 15.22-221.42.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -8.3, Earnings Per Share (EPS) of $-26.75, annual revenue of $1.28M.
The stock has a beta of 1.53, operates in the Healthcare sector.
